Gennady I. Kostyuchenko
Gennady I. Kostyuchenko has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Irina Ya. Tseimakh
Altai State Medical University
3 shared publications - Alexander E. Tseimakh
Altai State Medical University, Barnaul
2 shared publications Barnaul Regional Clinical Hospital
2 shared publications- Nadezhda G. Veselovskaya
Altai State Medical University
2 shared publications - Yakov N. Shoikhet
Altai State Medical University, Barnaul, Russia
2 shared publications - Yuri G. Motin
Altai State Medical University
2 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 87,p. 8-17
Impact of correction of homocisteinemia on clinical outcomes of lung damage associated with COVID-19 coronavirus infection
Aim. To assess the effect of serum homocysteine levels on treatment outcomes in patients with COVID19-associated lung damage, depending on the use of folic acid in complex treatment.Materials and methods. An open, prospective comparative study included 71 hospitalized adult patients with COVID-19-associated lung disease who did not require mechanical ventilation. The main group included 51 patients who received folic acid 15 mg per day in a complex treatment in a fixed combination with pyridoxine hydrochloride and cyanocobalamin. The comparison group included 20 patients in whose therapy folic acid was not used.Results. The use of folic acid was accompanied by a decrease in serum homocysteine concentration by 2.120 (-0.230; 3.680) µmol/L (p=0.004). When constructing a logistic regression model, the effect of a decrease in serum homocysteine (OR 1.289; 95% CI 1.026‒1.620; p=0.029), methylenetetrahydrofolate reductase MTHFR C677T genotype (OR 10.897; 95% CI 1.240‒95.772; p=0.031) on the achievement of 7th day of hospitalization, the cessation of isolation of SARS-CoV-2 virus RNA from the respiratory tract. Multiple linear regression analysis showed an association between the duration of hypoxemic respiratory failure, determined with SaO2≤93%, with the degree of change in serum homocysteine concentration after treatment, single nucleotide polymorphisms of methylenetetrahydrofolate reductase MTHFR C677T, methionine synthase MTR A2756G and methionine synthase reductase MTRR A66G, initial volume of lung damage ≥50% according to CT data, indicators of D-dimers, C-reactive protein, hemoglobin, platelets, concomitant hypertension, diabetes mellitus (R=0.699; R2=0.489; p=0.005).Conclusion. The dynamics of the decrease in serum homocysteine after treatment is an important predictor of the cessation of isolation from the respiratory tract of the SARS-CoV-2 virus RNA on the 7th day of treatment, reducing the duration of hypoxemic respiratory failure in patients with lung damage associated with COVID-19 infection.
- 3 April 2023
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 87,p. 8-17
Open AccessImpact of correction of homocisteinemia on clinical outcomes of lung damage associated with COVID-19 coronavirus infection
Aim. To assess the effect of serum homocysteine levels on treatment outcomes in patients with COVID19-associated lung damage, depending on the use of folic acid in complex treatment.Materials and methods. An open, prospective comparative study included 71 hospitalized adult patients with COVID-19-associated lung disease who did not require mechanical ventilation. The main group included 51 patients who received folic acid 15 mg per day in a complex treatment in a fixed combination with pyridoxine hydrochloride and cyanocobalamin. The comparison group included 20 patients in whose therapy folic acid was not used.Results. The use of folic acid was accompanied by a decrease in serum homocysteine concentration by 2.120 (-0.230; 3.680) µmol/L (p=0.004). When constructing a logistic regression model, the effect of a decrease in serum homocysteine (OR 1.289; 95% CI 1.026‒1.620; p=0.029), methylenetetrahydrofolate reductase MTHFR C677T genotype (OR 10.897; 95% CI 1.240‒95.772; p=0.031) on the achievement of 7th day of hospitalization, the cessation of isolation of SARS-CoV-2 virus RNA from the respiratory tract. Multiple linear regression analysis showed an association between the duration of hypoxemic respiratory failure, determined with SaO2≤93%, with the degree of change in serum homocysteine concentration after treatment, single nucleotide polymorphisms of methylenetetrahydrofolate reductase MTHFR C677T, methionine synthase MTR A2756G and methionine synthase reductase MTRR A66G, initial volume of lung damage ≥50% according to CT data, indicators of D-dimers, C-reactive protein, hemoglobin, platelets, concomitant hypertension, diabetes mellitus (R=0.699; R2=0.489; p=0.005).Conclusion. The dynamics of the decrease in serum homocysteine after treatment is an important predictor of the cessation of isolation from the respiratory tract of the SARS-CoV-2 virus RNA on the 7th day of treatment, reducing the duration of hypoxemic respiratory failure in patients with lung damage associated with COVID-19 infection.
- Open Access
- 31 May 2022
- Published by Reaviz Medical University in MORPHOLOGICAL NEWSLETTER
- Vol. 30 (3) , 30-36
THE LATE DIAGNOSIS OF DANON DISEASE: THE MORPHOLOGICAL CHARACTERISTICS OF LAMP2-CARDIOMYOPATHY (CASE REPORT)
Danons disease is a rare and difficult-to-diagnose X-linked hereditary disease caused by a deficiency of lysosome-associated membrane protein 2 or LAMP2. The main clinical symptoms include myocardial damage with the development of hypertrophic LAMP2 cardiomyopathy, skeletal myopathy, and intellectual impairment. The disease is characterized by a rapidly progressive course, which requires dynamic monitoring of patients. The most significant adverse prognostic factor and the main cause of death is the development of cardiomyopathy. But lysosomal accumulation of glycogen in cardiomyocytes often remains unrecognized as the cause of hypertrophic cardiomyopathy. The aim of the study was to conduct a clinical and morphological analysis of a case of late diagnosis of LAMP2 cardiomyopathy in a 44-year-old female patient. We used data from the medical history, the results of intravital laboratory and instrumental studies, qualitative and quantitative morphological studies of endomyocardial biopsy. The results of the study present clinical signs, the results of a morphological study at the light-optical and electronic microscopic levels, and show the features of the structural rearrangement of cardiomyocytes. The formation of multilamellar myelin-like structures under the sarcolemma of cardiomyocytes was found. There were signs of cell damage - significant uneven vacuolization of the sarcoplasm with the detection of fragments of PAS-positive content in individual vacuoles, distortion of cardiomyocytes. There was a disappearance of transverse striation and local violations of the integrity of the sarcolemma. The interstitium was characterized by loose lymphomononuclear infiltration with an admixture of single segmented leukocytes, edema, and small-focal sclerosis, predominantly of the perimuscular type. In the elements of the microvasculature at the light-optical level, signs of endothelial activation were observed. Based on the combination of clinical and anamnestic data, the results of molecular genetic, morphological studies, a metabolic cause of myocardial hypertrophy, previously not clinically recognized, was established with a morphological picture of LAMP2 cardiomyopathy - Danon disease, and an appropriate diagnosis was made. The authors present a rare case of late detection of Danon disease (LAMP2-cardiomyopathy) with the accumulation of autophagocytic material, glycogen in the sarcoplasm of cardiomyocytes, and the formation of osmiophilic myelin-like structures. The presented clinical case clearly demonstrates the practical significance of ultrastructural pathological examination of endomyocardial biopsy to determine the true form of metabolic hypertrophy and assess the degree of morphological myocardial rearrangement.
- 31 May 2022
- Published by Reaviz Medical University in MORPHOLOGICAL NEWSLETTER
- Vol. 30 (3) , 30-36
Open AccessTHE LATE DIAGNOSIS OF DANON DISEASE: THE MORPHOLOGICAL CHARACTERISTICS OF LAMP2-CARDIOMYOPATHY (CASE REPORT)
Danons disease is a rare and difficult-to-diagnose X-linked hereditary disease caused by a deficiency of lysosome-associated membrane protein 2 or LAMP2. The main clinical symptoms include myocardial damage with the development of hypertrophic LAMP2 cardiomyopathy, skeletal myopathy, and intellectual impairment. The disease is characterized by a rapidly progressive course, which requires dynamic monitoring of patients. The most significant adverse prognostic factor and the main cause of death is the development of cardiomyopathy. But lysosomal accumulation of glycogen in cardiomyocytes often remains unrecognized as the cause of hypertrophic cardiomyopathy. The aim of the study was to conduct a clinical and morphological analysis of a case of late diagnosis of LAMP2 cardiomyopathy in a 44-year-old female patient. We used data from the medical history, the results of intravital laboratory and instrumental studies, qualitative and quantitative morphological studies of endomyocardial biopsy. The results of the study present clinical signs, the results of a morphological study at the light-optical and electronic microscopic levels, and show the features of the structural rearrangement of cardiomyocytes. The formation of multilamellar myelin-like structures under the sarcolemma of cardiomyocytes was found. There were signs of cell damage - significant uneven vacuolization of the sarcoplasm with the detection of fragments of PAS-positive content in individual vacuoles, distortion of cardiomyocytes. There was a disappearance of transverse striation and local violations of the integrity of the sarcolemma. The interstitium was characterized by loose lymphomononuclear infiltration with an admixture of single segmented leukocytes, edema, and small-focal sclerosis, predominantly of the perimuscular type. In the elements of the microvasculature at the light-optical level, signs of endothelial activation were observed. Based on the combination of clinical and anamnestic data, the results of molecular genetic, morphological studies, a metabolic cause of myocardial hypertrophy, previously not clinically recognized, was established with a morphological picture of LAMP2 cardiomyopathy - Danon disease, and an appropriate diagnosis was made. The authors present a rare case of late detection of Danon disease (LAMP2-cardiomyopathy) with the accumulation of autophagocytic material, glycogen in the sarcoplasm of cardiomyocytes, and the formation of osmiophilic myelin-like structures. The presented clinical case clearly demonstrates the practical significance of ultrastructural pathological examination of endomyocardial biopsy to determine the true form of metabolic hypertrophy and assess the degree of morphological myocardial rearrangement.
- 1 January 2022
- Published by FSBSI Research Institute of Human Morphology in CLINICAL AND EXPERIMENTAL MORPHOLOGY
- Vol. 11 (4)
Morphological features of the myocardium in LAMP2-cardiomyopathy
We present a clinical and morphological case study of a delayed LAMP2-cardiomyopathy (Danon disease) in a 44-year-old woman. LAMP2-cardiomyopathy is caused by impaired autophagy processes due to lysosome-associated membrane protein-2 (LAMP-2) deficiency in cardiomyocytes. This is a rare and diagnostically challenging condition inherited in an X-linked dominant pattern. A medical triad includes myocardial damage with hypertrophic LAMP2-cardiomyopathy, intellectual disability, and skeletal myopa-thy, the first one being the most significant prognostic factor and the main cause of death in these patients. However, autophagy disturbance and lysosomal glycogen accumulation in cardiomyocytes often remain unrecognized as the cause of hypertrophic cardiomyopathy. The report briefly describes disease etiology and epidemiology and outlines the clinical findings of the morphological study focusing on intravital ultra-structural features of structural changes in the myocardium. We provide data from the patient’s history, the results of laboratory and imaging studies, as well as endomyocardial biopsy examination at the light-optical and electron microscopic levels. Keywords: Danon disease, hypertrophic cardiomyopathy, LAMP2, electron microscopy
- 1 January 2022
- Published by FSBSI Research Institute of Human Morphology in CLINICAL AND EXPERIMENTAL MORPHOLOGY
- Vol. 11 (4)
Morphological features of the myocardium in LAMP2-cardiomyopathy
We present a clinical and morphological case study of a delayed LAMP2-cardiomyopathy (Danon disease) in a 44-year-old woman. LAMP2-cardiomyopathy is caused by impaired autophagy processes due to lysosome-associated membrane protein-2 (LAMP-2) deficiency in cardiomyocytes. This is a rare and diagnostically challenging condition inherited in an X-linked dominant pattern. A medical triad includes myocardial damage with hypertrophic LAMP2-cardiomyopathy, intellectual disability, and skeletal myopa-thy, the first one being the most significant prognostic factor and the main cause of death in these patients. However, autophagy disturbance and lysosomal glycogen accumulation in cardiomyocytes often remain unrecognized as the cause of hypertrophic cardiomyopathy. The report briefly describes disease etiology and epidemiology and outlines the clinical findings of the morphological study focusing on intravital ultra-structural features of structural changes in the myocardium. We provide data from the patient’s history, the results of laboratory and imaging studies, as well as endomyocardial biopsy examination at the light-optical and electron microscopic levels. Keywords: Danon disease, hypertrophic cardiomyopathy, LAMP2, electron microscopy
- Open Access
- 1 January 2021
- Published by Krasnoyarsk State Medical University in Siberian Medical Review
- Vol. 6, 60-69
Effect of folic acid in patients with lung damage caused by coronavirus SARS-CoV-2
- 1 January 2021
- Published by Krasnoyarsk State Medical University in Siberian Medical Review
- Vol. 6, 60-69
Open AccessEffect of folic acid in patients with lung damage caused by coronavirus SARS-CoV-2
- Open Access
- 1 January 2012
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- No. 2,p. 40-45-45
Effects of therapy with systemic glucocorticosteroids on endothelial function and hemostasis in patients with infective exacerbation of chronic obstructive pulmonary disease
Резюме. Была проанализирована динамика основных показателей функциональной активности сосудистого эндотелия и тромбинемии у 111 больных с инфекционно-зависимым обострением хронической обструктивной болезни легких на фоне терапии системными глюкокортикостероидами (сГКС). Выявлено повышение уровней маркеров эндотелиальной дисфункции эндотелина-1 и гомоцистеина, значительное повышение содержания в плазме D-димеров, изменение агрегационной функции тромбоцитов. Терапия сГКС сопровождалась уменьшением уровней эндотелина-1 и D-димеров, находившихся в прямой корреляционной связи с показателем С-реактивного белка. При достижении ремиссии сохранялось повышение уровня D-димеров, что указывает на тромбогенный и тромбоэмболический риск у пациентов с коморбидностью по заболеваниям сердечно-сосудистой системы.
- 1 January 2012
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- No. 2,p. 40-45-45
Open AccessEffects of therapy with systemic glucocorticosteroids on endothelial function and hemostasis in patients with infective exacerbation of chronic obstructive pulmonary disease
Резюме. Была проанализирована динамика основных показателей функциональной активности сосудистого эндотелия и тромбинемии у 111 больных с инфекционно-зависимым обострением хронической обструктивной болезни легких на фоне терапии системными глюкокортикостероидами (сГКС). Выявлено повышение уровней маркеров эндотелиальной дисфункции эндотелина-1 и гомоцистеина, значительное повышение содержания в плазме D-димеров, изменение агрегационной функции тромбоцитов. Терапия сГКС сопровождалась уменьшением уровней эндотелина-1 и D-димеров, находившихся в прямой корреляционной связи с показателем С-реактивного белка. При достижении ремиссии сохранялось повышение уровня D-димеров, что указывает на тромбогенный и тромбоэмболический риск у пациентов с коморбидностью по заболеваниям сердечно-сосудистой системы.